These inferior survival outcomes were also reinforced by the most extensive real-world evidence (RWE) retrospective NSCLC analysis of switch/sucrose non-fermenting (SWI/SWF) mutations, including SMARCA4 variants. This evidence concerns the gene SMARCA4 and non-small cell lung carcinoma.